Cross Country Healthcare Inc (CCRN) Stock Price & Analysis
Cross Country Healthcare Inc (CCRN) rose 0.00% to USD 13.18 as of June 10, 2026 at 06:04 UTC, according to Nexqual real-time market data.
CCRN last closed at USD 13.18; the session ranged USD 13.18–13.21 on volume of 474,651 shares. Market capitalization is $408.69M, with a 52-week range of USD 7.43–14.99 (NMS). Source: Nexqual, June 10, 2026 at 06:04 UTC.
Key Statistics (as of June 10, 2026 at 06:04 UTC)
| Price | USD 13.18 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 13.18 |
| Open | USD 13.18 |
| Day Range | USD 13.18 – 13.21 |
| 52-Week Range | USD 7.43 – 14.99 |
| Volume | 474,651 shares |
| Market Cap | $408.69M |
| Exchange | NMS |
Technical Analysis (CCRN)
Nexqual's technical model rates CCRN "BUY" based on 5 bullish and 1 bearish signals across 123 daily candles, as of June 10, 2026 at 06:04 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 77.99 (overbought) |
| vs SMA50 | Above (USD 11.3) |
| MACD | 0.52 (positive) |
Analyst Ratings (CCRN)
Wall Street analysts rate CCRN "Hold" based on 5 analysts, with a mean price target of USD 12.6 (range USD 10–13.25), per Nexqual as of June 10, 2026 at 06:04 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 5 |
| Mean Target | USD 12.6 |
| High Target | USD 13.25 |
| Low Target | USD 10 |
| Buy / Hold / Sell | 0 / 9 / 0 |
Earnings (CCRN)
| Next Earnings Date | 2026-08-05 |
|---|---|
| EPS Estimate | USD 0.02 |
| Revenue Estimate | $242.15M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD -0.03 vs est -0.05 ▲ beat |
| 2025-12-31 | USD -0.06 vs est 0.03 ▼ miss |
| 2025-09-30 | USD 0.03 vs est 0.04 ▼ miss |
| 2025-06-30 | USD -0.01 vs est 0.06 ▼ miss |
Source: Nexqual, June 10, 2026 at 06:04 UTC.
Financials & Fundamentals (CCRN)
| Total Revenue | $1.00B |
|---|---|
| Revenue Growth (YoY) | -17.80% |
| Gross Margin | +20.21% |
| Operating Margin | -0.81% |
| Profit Margin | -9.84% |
| ROE | -26.98% |
| Debt / Equity | 0.65 |
| Current Ratio | 3.29 |
| Total Cash | $105.58M |
| Total Debt | $2.04M |
| Free Cash Flow | $47.09M |
Source: Nexqual, June 10, 2026 at 06:04 UTC.
Financial Health Score (CCRN)
Nexqual rates Cross Country Healthcare Inc's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 06:04 UTC.
| Growth | Critical — Revenue -22% YoY (annual), sharp decline |
|---|---|
| Profitability | Weak — Gross margin 20%, operating -1% |
| Balance Sheet | Strong — $106M cash vs $2M debt, net cash position |
| Cash Flow | Mixed — FCF $47M, slim 4.5% margin |
| Efficiency | Critical — ROE -27%, ROA -0.1% |
Ownership (CCRN)
| Insider Ownership | +7.78% |
|---|---|
| Institutional Ownership | +95.19% |
| Shares Outstanding | 31.01M |
| Float | 29.70M |
| Short % of Float | +2.83% |
Source: Nexqual, June 10, 2026 at 06:04 UTC.
Leadership (CCRN)
Cross Country Healthcare Inc is led by Kevin Cronin Clark (age 64), Co-Founder, Chairman, President & CEO, per Nexqual as of June 10, 2026 at 06:04 UTC.
| Co-Founder, Chairman, President & CEO | Kevin Cronin Clark (age 64) |
|---|---|
| Executive VP & CFO | William J. Burns (age 55) |
| Group President of Delivery, CCN, CCA & CCE | Marc S. Krug (age 57) |
| Chief Operating Officer | Amiee Hawkins (age 45) |
| Vice President of Investor Relations | Joshua David Vogel |
Major Backers & Investors (CCRN)
Notable institutional backers of Cross Country Healthcare Inc include Boston Partners, American Century Companies Inc, Sio Capital Management, LLC, according to Nexqual as of June 10, 2026 at 06:04 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Boston Partners | 7.87% |
| American Century Companies Inc | 5.52% |
| Sio Capital Management, LLC | 3.4% |
| Quinn Opportunity Partners, LLC | 3.17% |
| Charles Schwab Investment Management, Inc. | 2.94% |
| Oddo BHF Asset Management SAS | 2.91% |
| Dana Investment Advisors, Inc. | 2.89% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 10.05% |
| Vanguard Group | 8.37% |
| Dimensional Fund Advisors | 4.98% |
Source: Nexqual, June 10, 2026 at 06:04 UTC.
From Cross Country Healthcare Inc's Latest SEC 10-K Filing (filed 2026-03-09)
Key Strengths & Strategy (as disclosed to the SEC)
- We have converted close to 100% of our MSPs onto Intellify ® , our SaaS-based, proprietary, vendor management system that provides analytics and real-time insights, with industry-leading dashboards and reporting. • Vendor Neutral Program.
- Staffing Industry Analysts recognized Cross Country Healthcare as a leading healthcare staffing firm in the U.S., with 3.0% market share in 2024.
- We also offer our Software as a Service (SaaS)-based, proprietary, vendor management technology, Intellify ® to facilities to manage all or a portion of their agency services.
- Some of these sophisticated applications are proprietary and are hosted in Tier 1 hosting facilities while other systems are SaaS-based and hosted by vendor partners.
Partnerships
- According to a survey by the American Health Care Association and National Center for Assisted Living, 94% of nursing homes deal with staffing shortages, and 46% limit new admissions due to workforce issues.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| KELYA | Kelly Services, Inc. | USD 11.71 | ▼ 0.51% |
| KFRC | Kforce, Inc. | USD 47.89 | ▲ 0.72% |
| AMN | AMN Healthcare Services Inc | USD 30.33 | ▼ 4.29% |
| CENTA | Central Garden & Pet Company | USD 36.49 | ▲ 3.34% |
| CNMD | CONMED Corporation | USD 36.9 | ▲ 4.95% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 06:04 UTC. This page is informational and not investment advice.